Press Releases

NASHVILLE, Tenn., Oct. 9, 2019 /PRNewswire/ -- SmileDirectClub, Inc. (Nasdaq: SDC) ("SmileDirectClub"), the industry pioneer and first direct-to-consumer medtech platform for teeth st

Read more...

PHILADELPHIA, Oct. 9, 2019 /PRNewswire/ -- ChemistryRx proudly introduces an innovative solution to getting kids to take daily topical medications when they have a chronic skin condition: GlitteRx

Read more...

LAUSANNE, Switzerland, Oct. 9, 2019 /PRNewswire/ -- Galderma, a global leader in skin health focused on developing innovative aesthetic solutions, recently announced the Phase 2 clinical trial results for its novel ready-to-use investigational botulinum toxin, QM1114. The multicenter, randomized, double-blind, placebo-controlled study suc

Read more...

CARY, N.C. and STATESVILLE, N.C., Oct. 9, 2019 /PRNewswire/ -- Physician practices struggling to comply with state government restrictions on opioid prescriptions now have an easy means of satisfying the requirements designed to prevent overdoses and drug misuse.

Read more...

MARTINSRIED, Germany and MUNICH, Oct. 9, 2019 /PRNewswire/ -- iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on novel immune checkpoint targets, today announced significant changes to the company's executive management team. Apollon Papadimitriou, Ph.D. was appo

Read more...

OAKLAND, Calif., Oct. 9, 2019 /PRNewswire/ -- Pacific College of Oriental Medicine ("PCOM"), a leader in integrative healthcare education, is the first regionally-accredited institution offering a college-level

Read more...

BERKELEY, Calif., Oct. 9, 2019 /PRNewswire/ -- Fauna Bio Inc., a biotechnology company leveraging the science of evolution and comparative genomics to discover new treatments for human diseases, announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the Office of Research and Infrastructure Programs (ORIP) of the National Instit

Read more...

GAITHERSBURG, Md., Oct. 9, 2019 /PRNewswire/ -- Digital Infuzion is proud to have been selected by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, as a coordinating center for the Collaborative Influenza Vaccine Innovation Centers (CIVICs). The CIVICs program aims to develop new flu vaccines and vaccine strate

Read more...

EXTON, Pa., Oct. 9, 2019 /PRNewswire/ -- Absorption Systems, a global leader in translational medicine, pharmacokinetic testing of drugs, and cell and gene therapy, an

Read more...